-+ 0.00%
-+ 0.00%
-+ 0.00%

Which Of These 3 ETFs Gives You Elbit Systems With Less Company Risk?

Simply Wall St·11/19/2026 14:17:21
Listen to the news

If you like Elbit Systems for its defense technology but hold it directly, you carry its company specific risks on your own. Simply Wall St flags that its aerospace arm faces a weak mix of projects and fairly flat aircraft production. If that side of the business stays sluggish while other units mature, Simply Wall St notes it could drag on overall sales and profit margins. Owning Elbit Systems through an ETF spreads that single stock impact across many holdings and also tones down its potential upside.

The fresh piece of news is Elbit Systems reporting 17% revenue growth in the third quarter of 2026 and reaching a record order book of $33b. Those new deals point to heavier demand for its defense gear and training services. You can look at tickers EIS, ISRA, and ITEQ as ways to hold Elbit Systems inside a broader fund portfolio.

Fund Elbit Systems weight Rank in fund by weight 5-year annualised return after fees Fee Assets
iShares MSCI Israel ETF (EIS) 5.24% #4 of 129 8.8% 0.59% US$815.85 million
VanEck Israel ETF (ISRA) 4.13% #5 of 83 5.3% 0.59% US$145.42 million
Amplify BlueStar Israel Technology ETF (ITEQ) 7.25% #2 of 61 -3.8% 0.75% US$96.77 million

Rather choose individual stocks than a fund? Explore 35 high quality undervalued stocks.

iShares MSCI Israel ETF (EIS)

EIS is built around Israeli financials and healthcare, with Diversified Banks at 24.1% and Pharmaceuticals at 13.6%. Elbit Systems is a meaningful defense position at 5.24% of the portfolio, so each US$1,000 you put into EIS holds about US$52 in Elbit Systems. The rest of your money leans on other large holdings such as Teva Pharmaceutical Industries and Bank Leumi le-Israel B.M, which depend on drug demand and banking activity rather than defense contracts.

A key risk for Elbit Systems is that its aerospace segment faces a weak project mix and relatively flat platform production. That issue is specific to the company, so EIS’s mix of banks, pharmaceutical stocks and other sectors can soften the hit if aerospace margins stay under pressure. You are still relying heavily on Israel’s equity market overall, which concentrates your exposure in a single country even as company level risk is spread out.

An ETF's price is just the sum of what it holds. Check whether EIS trades above or below its holdings' estimated cash flow value.

VanEck Israel ETF (ISRA)

Palo Alto Networks and Teva Pharmaceutical Industries dominate the top of ISRA, together covering 21.8% of the ETF. The portfolio closely resembles EIS, with large slices in Systems Software at 22.2% and Diversified Banks at 17.0%, plus smaller exposure to areas like Multi-line Insurance and Renewable Electricity. Elbit Systems is a modest piece of that mix at 4.13% of assets. As a result, US$1,000 in ISRA works out to about US$41 tied directly to Elbit Systems, rather than the whole position driving your outcome.

Elbit Systems carries a specific issue in its aerospace arm, where weaker projects and flat platform production could drag on revenue and net margins if other pieces of the business grow faster. ISRA holds only 4.1% of its money in Aerospace and Defense. Larger slices in software, financials and real estate mean investors tie Elbit Systems to a broader set of industries than the stock alone can offer.

Uncover whether ISRA has kept pace with the market over the past week, year and five years

Amplify BlueStar Israel Technology ETF (ITEQ)

ITEQ gives Elbit Systems real weight at 7.25% of the portfolio, so US$1,000 in the fund still ties about US$72 directly to the stock. About 47% of ITEQ overlaps ISRA, yet the line-up is not identical. The ETF leans hard into Systems Software at 30.1%, with further exposure to Application Software, IT consulting, and hardware areas like Semiconductors and Electronic Equipment. Large positions in Palo Alto Networks and JFrog keep the focus on Israel-aligned technology rather than a broad country basket.

Elbit Systems faces a softer aerospace segment, where weaker project mix and fairly flat platform production have been an issue. ITEQ has 8.6% in Aerospace and Defense, and its stakes in software and renewable electricity depend more on digital security, IT demand and power assets than on aircraft programs. That mix helps limit how much this company-specific challenge can sway the overall ETF, but investors still rely on Elbit Systems as a sizeable anchor in a concentrated technology fund.

See what you'd actually own if you bought ITEQ, from its 61 positions to how much sits in the top 10.

Choosing your Elbit Systems footing

Start with what you want Elbit Systems to be in your portfolio. Recent contract wins and the large order book give you a concrete business story to follow, yet the softer aerospace projects still hang over part of the company. ITEQ puts about US$72 of every US$1,000 into Elbit Systems and tilts heavily toward software and other tech, so you accept a higher fee of US$75 a year on US$10,000 and a smaller pool of 61 holdings.

EIS and ISRA both charge US$59 a year on US$10,000 and own more companies, at 129 and 83. You give up some Elbit Systems weight, down to US$52 or US$41 per US$1,000, in exchange for a broader mix built around banks, healthcare and software. Your choice is simple. Decide whether you care more about a bigger Elbit Systems slice or a wider set of businesses around a smaller one.

Palo Alto Networks is the largest holding in both ISRA and ITEQ, so you'd own it either way. Check whether Palo Alto Networks trades above or below its fair value.

Fund data as of 13 November 2026. Portfolio holdings as of 12 November 2026.